Second-line Anti-epileptics | RL vs. NS in SCD episode artwork

EPISODE · Oct 12, 2024 · 9 MIN

Second-line Anti-epileptics | RL vs. NS in SCD

from JournalFeed

The JournalFeed podcast for the week of Oct 7-11, 2024.These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.Tuesday Spoon Feed:ACEP released a clinical policy that addresses the choice of a second-line agent for adults with refractory seizures after adequate dosing of benzodiazepines.Friday Spoon Feed:Cavernous sinus thrombosis (CST) is a rare but serious thrombophlebitic disease that can be easy to miss in the emergency department setting. This article provides an overview of CST as well as some pearls for clinching this diagnosis for emergency medicine physicians.

Episode metadata supplied by the publisher feed · Published Oct 12, 2024

Embed this episode

NOW PLAYING

Second-line Anti-epileptics | RL vs. NS in SCD

0:00 9:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JournalFeed?

This episode is 9 minutes long.

When was this JournalFeed episode published?

This episode was published on October 12, 2024.

Can I download this JournalFeed episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!